LAG3 and diffuse large B-cell lymphoma: CD8+ T cells from patients with DLBCL were co-cultured with SU-DHL6 or OCI-LY3 cells and treated with LAG-3 and/or PD-1 blocking agents, followed by examination of SU-DHL6 or OCI-LY3 cell apoptosis.